Selecta Biosciences Stock Price - SELB

3.75
0.12 (3.31%)
Upgrade to Real-Time
Afterhours (Closed)
3.63
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Selecta Biosciences Inc SELB NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.16 -4.22% 3.63 3.60 3.91 3.80 3.79 20:00:00
Bid Price Ask Price Spread Spread % News
3.50 3.75 0.25 6.67% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
6,541 1,037,406 $ 3.74 $ 3,881,053 745,874 1.28 - 4.83
Last Trade Time Type Quantity Stock Price Currency
19:42:40 1 $ 3.75 USD

Selecta Biosciences Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 317.59M 87.49M 78.52M $ 6.68M $ - -1.22 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 3.00 10.30%

more financials information »

Selecta Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SELB Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.704.02013.603.83679,876-0.07-1.89%
1 Month3.024.29063.003.58754,6280.6120.2%
3 Months2.174.29061.422.73774,8581.4667.28%
6 Months1.564.831.352.92758,5832.07132.69%
1 Year2.104.831.282.71459,6701.5372.86%
3 Years13.9924.021.285.38332,909-10.36-74.05%
5 Years15.0027.99951.285.78263,915-11.37-75.8%

Selecta Biosciences Description

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company is engaged in using synthetic vaccine particle or SVP technology to discover and develop targeted therapies to modulate the immune system effectively and safely treat rare and serious diseases. It provides SVP for immune tolerance and stimulation. The company products in Phase 1 and Phase 2 include SEL-403 for Pancreatic Cancer and Mesothelioma, SEL-212 for Chronic Severe Gout, SEL-302 for Methylmalonic Acidemia (MMA) and SEL-313 for Ornithine Transcarbamylase Deficiency (OTC).


Your Recent History
NASDAQ
SELB
Selecta Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.